Oppenheimer & Co. Inc. Decreases Holdings in iShares Biotechnology ETF $IBB

Oppenheimer & Co. Inc. decreased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 12.5% during the 4th quarter, Holdings Channel.com reports. The fund owned 22,980 shares of the financial services provider’s stock after selling 3,287 shares during the period. Oppenheimer & Co. Inc.’s holdings in iShares Biotechnology ETF were worth $3,878,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Darwin Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $25,000. Ashton Thomas Securities LLC purchased a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth approximately $36,000. Parkside Financial Bank & Trust boosted its stake in shares of iShares Biotechnology ETF by 48.6% during the 3rd quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after acquiring an additional 87 shares in the last quarter. Close Asset Management Ltd boosted its stake in shares of iShares Biotechnology ETF by 25.5% during the 3rd quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after acquiring an additional 70 shares in the last quarter. Finally, Founders Financial Alliance LLC boosted its stake in shares of iShares Biotechnology ETF by 605.7% during the 3rd quarter. Founders Financial Alliance LLC now owns 374 shares of the financial services provider’s stock worth $54,000 after acquiring an additional 321 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $167.27 on Monday. The business’s 50 day simple moving average is $169.84 and its 200-day simple moving average is $168.65. iShares Biotechnology ETF has a 12 month low of $116.25 and a 12 month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a $0.1218 dividend. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.